Table 3.
Effect of starting age, ending age and PSA threshold, and frequency on cost-effectiveness
| Screening strategy | ICER ($/LYG) |
|---|---|
| Decreasing starting age | |
| 60(2)74 | -- |
| 55(2)74 | $27,600 |
| 50(2)74 | $80,900 |
| 40(2)74 | $494,000 |
|
Increasing ending age & threshold | |
| 50(2)69 | -- |
| 50(2)74,4.0 | dominated* |
| 50(2)74 | $48,100 |
| Increasing frequency | |
| 50(4)74 | -- |
| 50(A)74 | $68,500 |
| 50(2)74 | $1,150,000 |
Abbreviations: LYG, life-years gained; ICER, incremental cost-effectiveness ratio; see Table 2 for full screening strategy descriptions
Dominated strategies have a higher ICER (i.e., they are less cost-effective) than the next most effective strategy